XENO (Xeno Transplants) Total Receivables: $0.10 Mil (As of Mar. 2008)


What is Xeno Transplants Total Receivables?

Xeno Transplants XENO Total Receivables is $0.10 Mil as of Mar. 2008.

Xeno Transplants's Total Receivables for the quarter that ended in Mar. 2008 was $0.10 Mil.


Xeno Transplants Total Receivables Related Terms


Xeno Transplants Total Receivables Historical Data

* Premium members only.

The historical data trend for Xeno Transplants's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xeno Transplants Total Receivables Chart

Xeno Transplants Annual Data
Trend Jun05 Jun06 Jun07
Total Receivables
0.00 0.00 0.00

Xeno Transplants Quarterly Data
Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.03 0.10 0.10

Xeno Transplants Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.10 Mil mean?
Xeno Transplants (XENO) has a Total Receivables of $0.10 Mil as of Mar. 2008. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Xeno Transplants and its competitors.
Is Xeno Transplants' Total Receivables too high?
Xeno Transplants' current Total Receivables is $0.10 Mil.
How does Xeno Transplants' Total Receivables compare to PRTX and GWSN?
Xeno Transplants' Total Receivables of $0.10 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Xeno Transplants and its competitors. Xeno Transplants's current Total Receivables is $0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xeno Transplants stock overvalued right now?
Xeno Transplants (XENO) has a current Total Receivables of $0.10 Mil. The current Total Receivables is $0.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Xeno Transplants (XENO), the current Total Receivables is $0.10 Mil as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xeno Transplants Business Description

Address 143 Gardner Road, Brookline, MA, USA, 02445
Xeno Transplants Corp is a bio-technology research and development company, which intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.